Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetically engineered multi-component virus-like particles as veterinary vaccines

L D Pearson1, P Roy

  • 1Department of Microbiology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins 80523.

Immunology and Cell Biology
|October 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profilin-1 is a negative regulator of mammary carcinoma aggressiveness.

British journal of cancer·2007
Same author

Search for heavy long-lived particles that decay to photons at CDF II.

Physical review letters·2007
Same author

Polarizations of J/psi and psi(2S) mesons produced in pp collisions at square root s = 1.96 TeV.

Physical review letters·2007
Same author

Observation and mass measurement of the baryon Xib-.

Physical review letters·2007
Same author

Drug administration with ocular iontophoresis: reaching maturity.

Archivos de la Sociedad Espanola de Oftalmologia·2007
Same author

Diagnosis and treatment of depression in Alzheimer's disease: impact on mood and cognition.

Panminerva medica·2007

Engineered virus-like particles (VLPs) mimic bluetongue virus (BTV) structure without infectious genetic material. These BTV VLPs successfully induced protective immune responses in sheep, showing vaccine potential.

Area of Science:

  • Virology
  • Structural Biology
  • Vaccine Development

Background:

  • Multiprotein structures can be engineered to mimic virus particles.
  • These virus-like particles (VLPs) are non-infectious but can elicit protective immune responses.
  • This approach holds promise for developing safe and effective vaccines against viral agents.

Purpose of the Study:

  • To construct and characterize bluetongue virus (BTV)-like particles (VLPs) using recombinant baculoviruses.
  • To evaluate the immunogenicity and protective capacity of these BTV VLPs in an animal model.

Main Methods:

  • Co-infection of insect cells with two recombinant baculoviruses expressing BTV outer capsid proteins (VP2, VP5) and core proteins (VP3, VP7).
  • Characterization of synthesized VLPs for size, appearance, and biochemical composition compared to authentic BTV.

Related Experiment Videos

  • Immunization of sheep with BTV VLPs and subsequent challenge with infectious BTV.

    • Main Results:

    • Non-infectious, double-shelled VLPs resembling authentic BTV were successfully synthesized.
    • The VLPs comprised outer shell proteins (VP2, VP5) and core proteins (VP3, VP7) from BTV.
    • Sheep immunized with BTV VLPs produced neutralizing antibodies against homologous BTV serotypes.

    Conclusions:

    • Simultaneous expression and assembly of VLP components demonstrate a novel approach for vaccine production.
    • Engineered BTV VLPs can elicit protective immune responses, indicating their potential as safe and effective vaccine candidates.
    • This VLP technology offers a versatile platform for developing vaccines against various viral diseases.